GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis

van der Waal JM, Wijma S
Record ID 32018001606
Dutch
Original Title: GVS advice concerning romosozumab (Evenity®)
Authors' objectives: GVS advice concerning romosozumab (Evenity®)
Details
Project Status: Completed
Year Published: 2020
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: The Netherlands
MeSH Terms
  • Fractures, Bone
  • Bone Density
  • Antibodies, Monoclonal
  • Bone Density Conservation Agents
  • Female
  • Osteoporosis, Postmenopausal
  • Osteoporosis
Contact
Organisation Name: The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address: Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name: Timon Sibma
Contact Email: TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.